Italo Porto

University of Genoa

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (23)

Collaborators (21)

Thomas Pilgrim

Ferenc Nagy

Associate Professor

University of Szeged

Danilo Neglia

Affiliate Professor

Scuola Superiore Sant'Anna

Filippo Ansaldi

Full Professor

University of Genoa

Giacomo Tini

Sapienza University of Rome

Markus Mach

Deputy Head of the Surgical-Interventional Hybrid OR Program

Medical University of Vienna

Ana Gomes de Almeida

Associate Professor with Aggregation of Cardiology and Consultant Cardiologist

Gianluca Pontone

University of Milan

Bram Roosens

Vrije Universiteit Brussel

Gaetano Maria De Ferrari

University of Turin

Borut Jug

Alessandro Sticchi

Assistant professor

University of Pisa

Flavio Luciano Ribichini

University of Verona

Róbert Sepp

University of Szeged

Andrea Igoren Guaricci

Tobias Zeus

University Hospital Düsseldorf

MARCO CANEPA

University of Genoa

Lorenzo Bianchi

Maastricht University Medical Centre

Lígia Mendes

Head of the Cardiology Department

Hospital da Luz

Pietro Ameri

University of Genova

Alessandro Santo Bortone

Assistant Professor in Medicine

University of Bari Aldo Moro

Italo Porto

Research Interests

Explore related searches

Contact this professor

Articles (23)

Practical considerations about management of pulmonary embolism in patients with cancer

Diuretic strategies in acute heart failure: a systematic review and network meta-analysis of randomized clinical trials

Treatment of impending paradoxical embolism with systemic thrombolysis and cerebral embolic protection: a case report

Gender-Specific Outcomes in TAVI with Self-Expandable Valves: Insights from a Large Real-World Registry

Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A systematic review and meta-analysis

Comparison of Mid-Term Prognosis in Intermediate-to-Low-Risk Contemporary Population with Guidelines-Oriented Age Cutoff

Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation

Provisional Circulatory Support with Extracorporeal Membrane Oxygenation during Ventricular Tachycardia Ablation in Intermediate Risk Patients: A Case Series

Aspirin in Primary Prevention: Looking for Those Who Enjoy It

Author Correction: Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction

Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction

Impaired Culprit-Vessel Flow Affects Percutaneous Coronary Intervention Outcomes in Spontaneous Coronary Artery Dissections

Risk Score for Prediction of Dialysis After Transcatheter Aortic Valve Replacement

Use of cardiac imaging in chronic coronary syndromes

Long-Term Outcomes of Transvenous Lead Extraction: A Comparison in Patients with or without Infection from the Italian Region with the Oldest Population

Role of Intracoronary Imaging in Myocardial Infarction with Non-Obstructive Coronary Disease (MINOCA): A Review

[New frontiers in antiplatelet therapy: guided therapy and de-escalation after acute coronary syndrome or percutaneous coronary intervention].

Clinical and angiographic features of SCAD type 4.

Correction to: Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.

Corrigendum to "Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy" [Int J Cardiol. 2022 Sep 15;363:111-118].

Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis

Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents?

Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents?

Collaborators (21)

Thomas Pilgrim

Ferenc Nagy

Danilo Neglia

Filippo Ansaldi

Giacomo Tini

Markus Mach

Ana Gomes de Almeida

Gianluca Pontone

Bram Roosens

Gaetano Maria De Ferrari

Borut Jug

Alessandro Sticchi

Flavio Luciano Ribichini

Róbert Sepp

Andrea Igoren Guaricci

Tobias Zeus

MARCO CANEPA

Lorenzo Bianchi

Lígia Mendes

Pietro Ameri

Alessandro Santo Bortone

How do I reach out?

Meet Kite AI